Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Earnings Call

Core Scientific Earnings Call: Key Takeaways

Core Scientific is successfully transitioning to a pure-play AI infrastructure provider, leveraging massive contracts with CoreWeave and AMD to drive significant sequential revenue and EBITDA growth despite regulatory and financing headwinds.

Full earnings call on the Alfa Finder USA YouTube channel · Open on YouTube ↗
Highlights
Revenue GrowthGap co-location revenue increased 60% sequentially to $215 million.
Mgmt ConfidenceHigh confidence in delivering 1.1GW contracted capacity despite political shifts.
Demand Visibility1.1GW contracted; 1.9GW AMD reservation rights with 2027-2028 deadlines.
Order Book1.1GW contracted capacity; $1.8B expected annual run rate revenue.
Margin TrendsAdjusted EBITDA margin expanded to 57% from 25% last quarter.
Op. LeverageEBITDA tripled on 60% revenue growth, showing massive fixed-cost leverage.
Pricing PowerAMD pricing reflects prevailing rates and development costs for future capacity.
Vol vs PriceGrowth driven by 90MW additional capacity brought into billing this quarter.
Segment GrowthCo-location revenue up 60%; Bitcoin mining being exited by year-end.
New ClientsSecured AMD contract for 530MW initial capacity across five campuses.
Capex & Debt$540M CAPEX; $440M Polaris acquisition; $1.7B total liquidity available.
RegulatoryNavigating ERCOT Bad Zero process; pending air permits for backup generators.
CommentaryCapital availability is the primary throttle for new AI infrastructure development.
New LaunchesDeveloping 10.6 mile natural gas pipeline for on-site power at Pecos.

Growth

Co-location revenue grew 60% sequentially to $215M; adjusted EBITDA tripled to $134M.

Outlook

Contracted portfolio expected to generate $1.8B annual revenue and $1.6B NOI when fully delivered.

Risks

Management used vague language regarding specific air permit timelines and potential Texas regulatory clawbacks.

Source

The company's earnings call, NASDAQ: CORZ, and its 8-K filed with the SEC. Summary written with AI assistance from the call.

Read the 8-K ↗

Core Scientific, Inc.: key numbers

Share price
$13.58Close, Nov 16
Market cap
$4.38B
Shares outstanding
322.24MLatest SEC cover page
Sector
Crypto Assets
Industry
Finance ServicesSIC 6199

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Core Scientific, Inc.

All →
4:36 PM ET Form 4
Insider Selling

Core Scientific Insider Todd M. Duchene Sells $125K of Stock

Todd M. Duchene sold 10,000 shares of Core Scientific, Inc. at $12.39 to $12.70 a share (average $12.45) in 2 transactions, worth $125K in total on Nov 9, 2026. Shares held after the trade: 1,113,286 (-0.2%).

Value
$125K
Shares
10,000
Average price
$12.45
Holding change
-0.2%
Trade date
Nov 9, 2026
8:10 AM ET 10-Q
Financial Results ▶ Call

Core Scientific Q3 2026 Results: Turns Profitable, Net Income $1.18B

Core Scientific reported a significant shift in its business model, with colocation revenue growing to $215.4 million for the quarter ended September 30, 2026, compared to $15.0 million in the prior year, driven by high-performance computing (HPC) initiatives. Despite a net loss of $324.4 million for the nine-month period, the company achieved a net income of $1.18 billion in the third quarter, primarily due to a $1.03 billion favorable change in the fair value of warrant liabilities.

Key figure
Net income $1.18B
7:06 AM ET 8-K
Financial Results

Core Scientific Financial Results

Core Scientific reported third quarter 2026 financial results, highlighted by a nearly 60% sequential increase in colocation revenue to $215.4 million. The company achieved net income of $1.2 billion, primarily driven by a non-cash gain from the change in fair value of warrants, and significantly expanded its Adjusted EBITDA margins to 57%.

“Our execution at scale is translating into results, with a significant sequential increase in GAAP colocation revenue. We are nearing full delivery under our first colocation agreement while construction under our second is underway across five campuses. With revenue growing and substantial contracted capacity still to deliver, we have built a strong foundation for our next phase of growth.”

Adam Sullivan, Chief Executive Officer of Core Scientific
4:22 PM ET Form 4
Insider Selling

Core Scientific Insider Todd M. Duchene Sells $126K of Stock

Todd M. Duchene sold 9,900 shares of Core Scientific, Inc. at $12.78 a share, worth $126K in total on Nov 2, 2026. Shares held after the trade: 1,123,386 (-0.9%).

Value
$126K
Shares
9,900
Price
$12.78
Holding change
-0.9%
Trade date
Nov 2, 2026
4:19 PM ET Form 4
Insider Selling

Core Scientific Insider Todd M. Duchene Sells $136K of Stock

Todd M. Duchene sold 10,000 shares of Core Scientific, Inc. at $13.27 to $13.80 a share (average $13.56) in 2 transactions, worth $136K in total on Oct 26, 2026. Shares held after the trade: 1,133,286 (-0.5%).

Value
$136K
Shares
10,000
Average price
$13.56
Holding change
-0.5%
Trade date
Oct 26, 2026
4:06 PM ET Form 4
Insider Selling

Core Scientific Insider Todd M. Duchene Sells $139K of Stock

Todd M. Duchene sold 10,000 shares of Core Scientific, Inc. at $13.87 a share, worth $139K in total on Oct 19, 2026. Shares held after the trade: 1,143,286 (-0.9%).

Value
$139K
Shares
10,000
Price
$13.87
Holding change
-0.9%
Trade date
Oct 19, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.